Clinical phenotype of Parkinson disease dementia

@article{Galvin2006ClinicalPO,
  title={Clinical phenotype of Parkinson disease dementia},
  author={J. Galvin and J. Pollack and John C. Morris},
  journal={Neurology},
  year={2006},
  volume={67},
  pages={1605 - 1611}
}
Objective: To determine which clinical features best characterize Parkinson disease dementia (PDD), compared with Alzheimer disease (AD) and dementia with Lewy bodies (DLB), and to determine the pathologic basis for PDD. Methods: We examined 103 participants enrolled in a longitudinal study (nondemented control = 10, PD = 42, DLB = 20, AD = 31) who were followed to autopsy using standardized protocols. We characterized the features of PDD using published criteria for AD and DLB as a framework… Expand
Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology
TLDR
It is suggested that it is difficult to distinguish PDD+AD and PDD−AD on the basis of movement, clinical, and neuropsychologic assessment. Expand
Clinical utility of the clinical dementia rating scale for Parkinson’s disease dementia
The purpose of this study is to explore validity of the Clinical Dementia Rating Scale (CDR) in measuring dementia among individuals with Parkinson’s disease. The CDR was created for use in patientsExpand
Pathologic Correlates of Dementia in Individuals with Lewy Body Disease
Cognitive impairment and dementia are more common in patients with Parkinson disease (PD) than age‐matched controls and appear to become more frequent as PD progresses. However, estimates of dementiaExpand
Parkinson's disease dementia: a diminished role for the Lewy body.
TLDR
The findings from this study do not support the hypothesis that LBs are the main substrate for dementia in PD, and the entire role of the LB in PD dementia is again brought into question. Expand
Cognitive Change in Parkinson Disease
  • J. Galvin
  • Psychology, Medicine
  • Alzheimer disease and associated disorders
  • 2006
TLDR
The clinical, cognitive, neuropsychiatric features of cognitive deficits associated with PD are examined, their pathologic basis is discussed, and avenues for future research are proposed. Expand
Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment
TLDR
Further research on PD‐specific tools seems mandatory to help establish accurate cut‐off scores for the diagnosis of mild PDD, detect cognitive profiles more prone to the future development of dementia, and allow comparisons between different descriptive or interventional studies. Expand
Crossover between Lewy Body Pathology and Alzheimer ’ s Dementia
Several recent studies have shown that dementia is common in Parkinson’s Disease (PD), and that in some patients, cognitive impairment occurs even at the time of diagnosis. The point prevalence ofExpand
Cognitive decline in Parkinson’s disease: the complex picture
TLDR
Evidence from neuroimaging studies using different methods and techniques suggests that in addition to degeneration of the dopaminergic system, other mechanisms have a role including β-amyloid and tau deposition, and that specific cognitive scales could help identifying a malignant profile. Expand
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
TLDR
The data suggest an influence of Alzheimer-related lesions on the progression of the neurodegenerative process and, in particular, on cognitive decline in both PDD and DLB. Expand
Update on Dementia with Lewy Bodies
Dementia with Lewy bodies (DLB) is the second most common form of dementia after Alzheimer disease (AD). DLB is characterized pathologically by Lewy body and Lewy neuritic pathology, often withExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 64 REFERENCES
Risk of dementia in Parkinson’s disease
TLDR
Patients with PD have an almost sixfold increased risk for becoming demented compared with subjects without PD. Expand
Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.
TLDR
Early hallucinations and akinetic-dominant PD were associated with an increased risk of dementia, and more than three quarters of this representative PD cohort developed dementia during the 8-year study period. Expand
Cognitive Predictors of Dementia in Parkinson’s Disease: A Community-Based, 4-Year Longitudinal Study
TLDR
It was concluded that poor performance on a test sensitive to executive dysfunction predicted later development of dementia in PD patients, and this finding may have important clinical implications as a marker of subsequentDevelopment of dementia. Expand
Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
TLDR
Increased age, depressive features, and even minimal cognitive impairment, as determined clinically by Clinical Dementia Rating sum of boxes and by slowed psychomotor performance, identify older individuals without dementia who develop dementia. Expand
Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.
TLDR
Based on neuropathological findings, damage not to a single, but to multiple neuronal networks including the innominatocortical cholinergic, ceruleocortICAL noradrenergic as well as mesocorticals dopaminergic systems could play a role in the development of dementia in PD. Expand
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
TLDR
Diffuse or transitional Lewy body disease is the primary pathologic substrate for dementia developing later in Parkinson disease and seemed to account for end-stage, levodopa refractory parkinsonism, suggesting common origins or one triggering the other. Expand
Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia
TLDR
It is concluded that patients with PD and MCI had a higher risk of developing dementia than cognitively intact PD patients, suggesting that MCI in PD is an early manifestation of dementia. Expand
Motor impairment in PD
TLDR
It is suggested that motor impairment mediated predominantly by nondopaminergic systems is associated with incident dementia in PD and axial impairment may be the result of a combined effect of the disease and the aging process. Expand
Mortality from Parkinson disease.
TLDR
Compared with nondemented elderly people in the same community, patients with PD have a 2- to 5-fold increased risk of mortality, and the risk is strongly related to the presence of severe EPSs, especially bradykinesia. Expand
A controlled, longitudinal study of dementia in Parkinson's disease.
TLDR
The patients with PD who became demented during follow up were older at onset of Parkinson's disease than patients who did not become demented, had a longer duration of Parkinson’s disease, and were Older at inclusion to the study. Expand
...
1
2
3
4
5
...